Search Results
Dec 22, 2025, 03:00 ET Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
aromatase inhibitors plus CDK4/6 inhibitors. CTC count is a standalone predictive biomarker, independent of clinical risk factors and circulating tumor DNA.BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 22, 2025 /PRNewswire/
More news about: Menarini Silicon Biosystems
Dec 22, 2025, 03:00 ET Menarini Silicon Biosystems annuncia la pubblicazione dei risultati dello studio PACE, che mostrano il valore clinico della conta delle cellule tumorali circolanti con CELLSEARCH® in uno specifico sottotipo di carcinoma mammario metastatico
delle CTC si è dimostrata un biomarcatore predittivo indipendente, non influenzato dai fattori di rischio clinici né dai risultati dell'analisi del DNA tumorale circolante (ctDNA).BOLOGNA, Italia e HUNTINGDON VALLEY, Pennsylvania,
More news about: Menarini Silicon Biosystems
Dec 22, 2025, 01:52 ET DFSK betritt mit strategischer Fahrzeugpalette offiziell den ägyptischen Markt
solide Grundlage für seinen Ruf der Zuverlässigkeit bildet. Vor dem Hintergrund des Zeitalters der Elektrifizierung hält die DFSK weiterhin an ihrer Kern-DNA der Zuverlässigkeit fest und steuert gleichzeitig mit einer nutzerzentrierten Denkweise. Angetrieben von neuen Energietechnologien und Innovationen,
More news about: DFSK
Dec 21, 2025, 22:27 ET DFSK Officially Enters the Egyptian Market with Strategic Vehicle Lineup
laying a solid foundation for its reputation for reliability. Against the backdrop of the electrification era, the DFSK continues to uphold its core DNA of reliability while steering with a user-centric mindset. Driven by new energy technologies and innovation, the brand is reshaping green and smart mobility.At
More news about: DFSK
Dec 21, 2025, 22:06 ET DFSK Officially Enters the Egyptian Market with Strategic Vehicle Lineup
laying a solid foundation for its reputation for reliability. Against the backdrop of the electrification era, the DFSK continues to uphold its core DNA of reliability while steering with a user-centric mindset. Driven by new energy technologies and innovation, the brand is reshaping green and smart mobility.
More news about: DFSK
Dec 19, 2025, 16:05 ET INOVIO Reports Inducement Grant Under Inducement Plan
biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting
More news about: INOVIO Pharmaceuticals, Inc.
Dec 19, 2025, 14:00 ET jscreen and the Mathew Forbes Romer Foundation Expand Multi-Year Partnership to Bring Lifesaving Genetic Testing Resources to South Florida
families across South Florida. These efforts are designed to encourage people of all ages to "take control of their future by taking control of their DNA."MFRF Brain Health HustleAs part of this initiative, jscreen and MFRF invite the community to join the 2nd
More news about: jscreen.org
Dec 19, 2025, 13:07 ET Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
Targeted Methylation Sequencing (dTMS) platform. The collaboration brings together Agilent's enrichment chemistries—SureSelect for genomic DNA and Avida for cell-free DNA—and WBL's proprietary Oxford Nanopore-based native-read workflow, expanding access to scalable targeted multi-omic analysis for RUO and
More news about: Wasatch BioLabs
Dec 19, 2025, 10:00 ET Italdesign USA: A Strategic Bridge Between Italy and Detroit
paper to production-ready vehicles, Italdesign USA offers seamless support through each step of the process. With creativity embedded in the company's DNA and unmatched engineering expertise, Italdesign USA delivers the comprehensive expertise that has made the Italdesign Group a unique name in the automotive
More news about: Italdesign
Dec 19, 2025, 09:00 ET Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to Outperform Docetaxel in a Head-to-Head Phase 3 Trial
to exceed the efficacy of docetaxel in a direct, head-to-head comparison, marking a significant evolution in treatment sequencing for patients with DNA damage repair (DDR)-deficient tumors.
More news about: TOLMAR
Dec 19, 2025, 06:55 ET CougarD Releases First "Professional Emotional DNA" Report: Why Many Men Are Finding Greater Success on CougarD
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- CougarD today released its first Professional Emotional DNA Report, a data-driven look at how women in finance, technology, healthcare, and entrepreneurship approach modern relationships-and what kinds of
More news about: CougarD
Dec 18, 2025, 20:24 ET Press Conference December 22nd Announcing: "Georgia Father Awarded Sole Custody in Landmark Legitimation Case After Mother Declared Brain Dead"
mother of his son, Mr. Harden anguished over the uncertainty of his future. Mr. Harden was further traumatized when he discovered that despite a positive DNA test administered at the hospital, he was at risk of not being able to take Baby Chance home, or worse, Baby Chance being placed in foster care by the
More news about: Better Law Divorce Lawyers
Dec 18, 2025, 14:00 ET Pesquisa inédita revela o "DNA do Caramelo" e identifica as raças e características mais comuns do cão mais querido do Brasil
parceria com a DNA Pets, a pesquisa reuniu uma base nacional de animais reconhecidos popularmente como Caramelos, identificando padrões genéticos, morfológicos e comportamentais que ajudam a compreender quem é, afinal, o cão mais amado do país.O estudo revelou o DNA do Caramelo tem
More news about: Mars Petcare
Dec 18, 2025, 13:58 ET Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
isotope supply they need."Ac-225 is one of the most promising radioisotopes in oncology as its emitted alpha particles deliver highly potent, DNA-damaging energy, enabling precise destruction of tumor cells while limiting harm to surrounding healthy tissue with targeted modalities like RCs. Despite
More news about: Niowave Inc.
Dec 18, 2025, 13:26 ET Rosalind Franklin University Secures $1.7M in NIH Funding to Advance Research on Social Recognition Mechanisms in Schizophrenia and Autism Spectrum Disorders
embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Dec 18, 2025, 09:00 ET Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Dec 18, 2025, 09:00 ET Phoenix Children's Research Institute Secures Three Prestigious National Institutes of Health (NIH) Grants
therapeutic agents selectively to lung cells.The research team at Phoenix Children's developed nanoparticles that deliver medicine or therapeutic DNA specifically to lung cells, sparing other organs. The delivered gene, FOXM1, supports cell regeneration and repair after injury, which could prevent
More news about: Phoenix Children's
Dec 18, 2025, 06:59 ET Viatris Provides Pipeline Update on Four Regulatory Milestones
therapy platform, a first-of-its-kind approach designed to be delivered directly to the lacrimal gland via a single injection, using non-replicating DNA delivery transporters for the production and delivery of human Nerve Growth Factor (hNGF) protein to the cornea via tears. NK is the first indication
More news about: Viatris Inc.
Dec 17, 2025, 13:31 ET POLARIS RZR FACTORY RACING DELIVERS MOST SUCCESSFUL SEASON IN UTV OFF-ROAD RACING HISTORY WITH UNDEFEATED 2025 CAMPAIGN
Midnight Blue Express snow team of the 1970s, when Polaris' original factory teams helped establish racing as a core pillar to the brand's identity. That DNA continues to shape the modern Polaris RZR Factory Racing program, influencing everything from vehicle development to the way Polaris approaches the world's
More news about: Polaris Inc.
Dec 17, 2025, 11:01 ET Washington Research Foundation announces 2026 cohort of WRF Postdoctoral Fellows
Affairs and NOAA's Northwest Fisheries Science Center, she will develop quantitative methods to estimate the abundance of phytoplankton from environmental DNA to improve detection and monitoring of harmful algal blooms.Nathaniel Ritz earned his Ph.D. in neuroscience from University College Cork
More news about: WASHINGTON RESEARCH FOUNDATION
Dec 17, 2025, 11:00 ET PRISM BioLab and Talus Bioscience Join Forces to Discover Novel Inhibitors of Transcription Factor and Protein-Protein Interaction Targets
discovery. Founded in 2020, the Seattle-based company's platform generates global profiles of the regulome, including transcription factors and other DNA regulators directly in native human cells. These quantitative maps of regulome activity unlock new avenues to target historically "undruggable" proteins
More news about: PRISM Biolab
Dec 17, 2025, 09:00 ET Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Dec 17, 2025, 08:45 ET Volition Issues Business Review 2025
with the potential for accurate, low-cost tests for a wide range of cancers. The 180-fold (18,000%) enrichment of ultrashort DNA, separating out the massive amounts of background DNA, is, we believe, a world-first breakthrough, and has generated significant interest from potential licensing partners. Independent
More news about: VolitionRx Limited
Dec 17, 2025, 08:22 ET International Bestseller God, The Science, The Evidence Offers a Science-Forward Case for Belief During the Holiday Season
challenged by modern developments in cosmology, physics, and biology—including the Big Bang, the fine-tuning debate, and the information-rich complexity of DNA."Many people live with an unresolved tension between what they were taught about science and what they feel drawn to spiritually," said co-author
More news about: Palomar Editions
Dec 17, 2025, 08:00 ET Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
solutions.BOSTON and PLANO, Texas, Dec. 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo"), a provider of research and development services and tools for biological product development and Agricen, a leader in the development and
More news about: Ginkgo Bioworks